Startseite>>Natural Products>>Tigloylgomisin H

Tigloylgomisin H

Katalog-Nr.GC37791

Tigloylgomisin H ist ein aus den FrÜchten von S. chinensis isoliertes Lignan, das die AktivitÄt der Chinonreduktase (QR) in Hepa1c1c7-Maus-Hepatokarzinomzellen induzieren kann. Tigloylgomisin H fungiert als monofunktionaler Induktor, der das Phase-II-Entgiftungsenzym NQO1 Über den NF-E2-verwandten Faktor 2 (Nrf2)-ARE-Weg spezifisch hochreguliert und somit ein potenzielles Mittel zur Vorbeugung von Leberkrebs darstellt.

Products are for research use only. Not for human use. We do not sell to patients.

Tigloylgomisin H Chemische Struktur

Cas No.: 66069-55-4

Größe Preis Lagerbestand Menge
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tigloylgomisin H is a lignan isolated from the fruits of S. chinensis, can induce quinone reductase (QR) activity in Hepa1c1c7 mouse hepatocarcinoma cells. Tigloylgomisin H functions as a monofunctional inducer that specifically upregulates phase II detoxification enzyme NQO1 through the NF-E2-related factor 2 (Nrf2)-ARE pathway, thus represents a potential liver cancer prevention agent[1].

[1]. Lee SB, et al. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta Med. 2009 Oct;75(12):1314-8.

Bewertungen

Review for Tigloylgomisin H

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tigloylgomisin H

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.